Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Nurse-Led program reverse frailty in dialysis patients?

NCT ID NCT07677085

Disease control Sponsor: Henan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study tests whether a 3-month nurse-led program can reduce frailty and improve self-management in people undergoing peritoneal dialysis. The program includes personalized assessments, education, exercise training, and social support. Researchers compare this program to standard care in 72 participants, measuring changes in frailty, nutrition, exercise confidence, and self-care behaviors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ITHBC-based comprehensive nursing intervention
What this could lead to
If successful, this program could offer a practical, non-drug way to reduce frailty and improve daily self-care for people on peritoneal dialysis.
What could go wrong
This is a small, early-stage study (72 participants) testing a behavioral intervention, so results may not apply broadly. Frailty improvements may be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Mar 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age ≥ 18 years; * a diagnosis of end-stage renal disease with an estimated glomerular filtration rate of \< 15 mL/min/1.73 m² ; * currently undergoing peritoneal dialysis with regular follow-up at the peritoneal dialysis clinic; * a score of ≥ 3 on the Fried Frailty Phenotype Scale; * provision of written informed consent and voluntary participation in this study. Exclusion Criteria: * presence of concurrent severe primary diseases, including malignant tumors; * cognitive impairment or a diagnosed mental illness; * limb dysfunction that precluded cooperation with the intervention.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty syndrome Peritoneal dialysis (PD)

Contacts and locations

Locations

  • Henan University School of Nursing and Health Sciences

    Kaifeng, Henan, 475001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.